Fundraising Fox

Sebacia

Duluth, US · Founded 2010 · Delaware corporation · 3 known investors

Healthtech

Founders & leadership

AV
Anthony V. LandoinExecutive
TMTodd Meyer
Todd MeyerinChief Operating Officer2010–2019
DP
Dilip PaithankerExecutive
RL
Robert LeslieExecutive
DP
Dilip PaithankarinExecutive

Board

RB
Rebecca B. RobertsonBoard director
GV
Gerard van Hamel PlaterinkBoard director
JTJesse Treu
Jesse Treuin𝕏Board directorPartner Emeritus at Domain Associates
TD
Thomas D. WeldonBoard director
TB
Todd BradyBoard director
NW
Neal WalkerBoard director

Investors · 3

Accuitive Medical Venturesreported
Domain Associatesreported · 2 sourcesPrinceton · $200K – $15Mvia Jesse Treu · board
Versant VenturesreportedSan Francisco · $250K – $5M

Reported raises · per SEC filings

Form D private placements

$50.1M disclosed across 4 rounds · 2014–2019

▶$10MraisedSep 2019 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecca S. RobertsonDirector
  • Neal WalkerDirector
  • Charles E. LarsonDirector
  • Charles AbrahamExecutive Officer, Director
  • John DyettDirector
  • Jesse TreuDirector
Offering amount
$15M
Amount sold
$10M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.1MraisedJul 2017 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert LeslieExecutive Officer
  • John DyettDirector
  • Anthony V. LandoExecutive Officer, Director
  • Neal WalkerDirector
  • Jesse TreuDirector
  • Thomas D. WeldonDirector
  • Rebecca B. RobertsonDirector
Offering amount
$26.1M
Amount sold
$21.1M
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedJun 2015 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecca B. RobertsonDirector
  • Anthony V. LandoExecutive Officer, Director
  • Gerard van Hamel PlaterinkDirector
  • Todd MeyerExecutive Officer
  • Jesse TreuDirector
  • Thomas D. WeldonDirector
  • Dilip PaithankerExecutive Officer
  • Robert LeslieExecutive Officer
  • Neal WalkerDirector
Offering amount
$12M
Amount sold
$8M
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11MraisedJun 2014 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert LeslieExecutive Officer
  • Todd BradyDirector
  • Anthony V. LandoExecutive Officer, Director
  • Dilip PaithankarExecutive Officer
  • Rebecca B. RobertsonDirector
  • Thomas D. WeldonDirector
  • Neal WalkerDirector
  • Gerard van Hamel PlaterinkDirector
Offering amount
$16M
Amount sold
$11M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Sebacia Announces $36 Million Equity And Debt Financing To Advance Breakthrough In-Office Procedure For Acne - BioSpacebiospace.com · Jul 2017Sebacia raises $22M to get gold microparticle acne treatment through FDA, launch | Fierce Biotechfiercebiotech.com · Jun 2015A phototherapy cream that kills acne: Sebacia raises $22Mmedcitynews.com · Jun 2015Sebacia raises $8M, nears FDA submission of laser-activated microparticles for acne | Fierce Pharmafiercepharma.com · Jun 2015Sebacia - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.comFull article: An Industry update: the Latest News in Therapeutic Deliverytandfonline.com

Frequently asked questions

Who are Sebacia's investors?
Sebacia's investors include Accuitive Medical Ventures, Domain Associates, Versant Ventures.
How much funding has Sebacia raised?
Sebacia has disclosed $50.1M raised across 4 rounds.
Where is Sebacia headquartered?
Sebacia is headquartered in Duluth, US.